Literature DB >> 20166878

Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease.

Alessandra Franco1, Chisato Shimizu, Adriana H Tremoulet, Jane C Burns.   

Abstract

Kawasaki disease (KD) is a pediatric self-limited vasculitis characterized by immune-mediated destruction of the arterial wall and myocardium. Neither the trigger that incites the inflammation nor the switch that turns it off is known. To further our understanding of KD pathogenesis and the role of regulatory T-cells in modulating the inflammatory response, we studied circulating effector memory T-cells (CCR7- and IL-15+ T(em)) and central memory T-cells (CCR7+ and IL-15+ T(cm)) in six KD subjects. In two of the subjects, we cloned the remaining T-cell population by limiting dilution. TaqMan analysis of T(em) studied in two KD subjects suggested that T(em) are pro-inflammatory CD4+T-helper 1 cells and CD8+ cytotoxic T-cells. Following memory T-cells over time, we defined that circulating T(em) and T(cm) are detectable during the acute phase in some KD subjects before treatment with intravenous immunoglobulin. Both T(em) and T(cm) expand rapidly within 2 weeks of treatment. The circulating T(em) pool contracts, while T(cm) further proliferate in the convalescent phase. Following depletion of memory T-cells, numerous T-cell clones were derived from two acute KD subjects. The large majority of these T-cells displayed the functional phenotype of peripherally induced regulatory T-cells (T(reg)). These findings provide insight into the nature and kinetics of the adaptive immune response in KD.

Entities:  

Mesh:

Year:  2010        PMID: 20166878      PMCID: PMC2871072          DOI: 10.3109/08916930903405891

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  32 in total

1.  Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide.

Authors:  M S Jordan; A Boesteanu; A J Reed; A L Petrone; A E Holenbeck; M A Lerman; A Naji; A J Caton
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

2.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

3.  Chemokines and leukocyte traffic.

Authors:  Federica Sallusto; Marco Baggiolini
Journal:  Nat Immunol       Date:  2008-09       Impact factor: 25.606

4.  CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease.

Authors:  T J Brown; S E Crawford; M L Cornwall; F Garcia; S T Shulman; A H Rowley
Journal:  J Infect Dis       Date:  2001-08-22       Impact factor: 5.226

5.  Origin of regulatory T cells with known specificity for antigen.

Authors:  Irina Apostolou; Adelaida Sarukhan; Ludger Klein; Harald von Boehmer
Journal:  Nat Immunol       Date:  2002-07-01       Impact factor: 25.606

6.  A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease.

Authors:  David Burgner; Sonia Davila; Willemijn B Breunis; Sarah B Ng; Yi Li; Carine Bonnard; Ling Ling; Victoria J Wright; Anbupalam Thalamuthu; Miranda Odam; Chisato Shimizu; Jane C Burns; Michael Levin; Taco W Kuijpers; Martin L Hibberd
Journal:  PLoS Genet       Date:  2009-01-09       Impact factor: 5.917

7.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

8.  RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease.

Authors:  Anne H Rowley; Susan C Baker; Stanford T Shulman; Francesca L Garcia; Linda M Fox; Ian M Kos; Susan E Crawford; Pierre A Russo; Rashid Hammadeh; Kei Takahashi; Jan M Orenstein
Journal:  PLoS One       Date:  2008-02-13       Impact factor: 3.240

9.  Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo.

Authors:  Lucy S K Walker; Anna Chodos; Mark Eggena; Hans Dooms; Abul K Abbas
Journal:  J Exp Med       Date:  2003-07-21       Impact factor: 14.307

Review 10.  Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight.

Authors:  Anne H Rowley; Susan C Baker; Jan M Orenstein; Stanford T Shulman
Journal:  Nat Rev Microbiol       Date:  2008-05       Impact factor: 60.633

View more
  29 in total

1.  Phase I/IIa Trial of Atorvastatin in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysm.

Authors:  Adriana H Tremoulet; Sonia Jain; Pei-Ni Jone; Brookie M Best; Elizabeth H Duxbury; Alessandra Franco; Beth Printz; Samuel R Dominguez; Heather Heizer; Marsha S Anderson; Mary P Glodé; Feng He; Robert L Padilla; Chisato Shimizu; Emelia Bainto; Joan Pancheri; Harvey J Cohen; John C Whitin; Jane C Burns
Journal:  J Pediatr       Date:  2019-09-24       Impact factor: 4.406

2.  Fine specificities of natural regulatory T cells after IVIG therapy in patients with Kawasaki disease.

Authors:  Jane C Burns; Ranim Touma; Yali Song; Robert L Padilla; Adriana H Tremoulet; John Sidney; Alessandro Sette; Alessandra Franco
Journal:  Autoimmunity       Date:  2015-03-30       Impact factor: 2.815

3.  Transforming growth factor-beta signaling pathway in patients with Kawasaki disease.

Authors:  Chisato Shimizu; Sonia Jain; Sonia Davila; Martin L Hibberd; Kevin O Lin; Delaram Molkara; Jeffrey R Frazer; Shelly Sun; Annette L Baker; Jane W Newburger; Anne H Rowley; Stanford T Shulman; Sonia Davila; David Burgner; Willemijn B Breunis; Taco W Kuijpers; Victoria J Wright; Michael Levin; Hariklia Eleftherohorinou; Lachlan Coin; Stephen J Popper; David A Relman; Wen Fury; Calvin Lin; Scott Mellis; Adriana H Tremoulet; Jane C Burns
Journal:  Circ Cardiovasc Genet       Date:  2010-12-02

4.  Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin.

Authors:  J C Burns; Y Song; M Bujold; C Shimizu; J T Kanegaye; A H Tremoulet; A Franco
Journal:  Clin Exp Immunol       Date:  2013-12       Impact factor: 4.330

Review 5.  The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease.

Authors:  Jane C Burns; Alessandra Franco
Journal:  Expert Rev Clin Immunol       Date:  2015       Impact factor: 4.473

6.  Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease.

Authors:  Adriana H Tremoulet; Paige Pancoast; Alessandra Franco; Matthew Bujold; Chisato Shimizu; Yoshihiro Onouchi; Alyson Tamamoto; Guliz Erdem; Debra Dodd; Jane C Burns
Journal:  J Pediatr       Date:  2012-04-06       Impact factor: 4.406

7.  The ion channel TRPV1 regulates the activation and proinflammatory properties of CD4⁺ T cells.

Authors:  Lilian L Nohara; Hongjian Xu; Samuel Bertin; Yukari Aoki-Nonaka; Petrus Rudolf de Jong; Shawna R Stanwood; Sonal Srikanth; Jihyung Lee; Keith To; Lior Abramson; Timothy Yu; Tiffany Han; Ranim Touma; Xiangli Li; José M González-Navajas; Scott Herdman; Maripat Corr; Guo Fu; Hui Dong; Yousang Gwack; Alessandra Franco; Wilfred A Jefferies; Eyal Raz
Journal:  Nat Immunol       Date:  2014-10-05       Impact factor: 25.606

8.  Plasma MASP-1 concentration and its relationship to recovery from coronary artery lesion in children with Kawasaki disease.

Authors:  Rui-Xia Song; Qing-Mei Zou; Xiao-Hui Li; Nan-Ping Xu; Ting Zhang; Jin Fu; Xiao-Dai Cui
Journal:  Pediatr Res       Date:  2015-11-04       Impact factor: 3.756

9.  The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease.

Authors:  Chisato Shimizu; Toshiaki Oharaseki; Kei Takahashi; Aubri Kottek; Alessandra Franco; Jane C Burns
Journal:  Hum Pathol       Date:  2012-09-03       Impact factor: 3.466

10.  Clinical characteristics of Kawasaki disease and concurrent pathogens during isolation in COVID-19 pandemic.

Authors:  Yue-Yue Ding; Yan Ren; Jie Qin; Guang-Hui Qian; Yun-Jia Tang; Ye Chen; Xuan Li; Lei Xu; Chun-Hong Qiao; Ling Sun; Hai-Tao Lv
Journal:  World J Pediatr       Date:  2021-06-23       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.